A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

Endocrinology
Zhi-Liang ChuJames Leonard

Abstract

We recently showed that activation of G protein-coupled receptor 119 (GPR119) (also termed glucose dependent insulinotropic receptor) improves glucose homeostasis via direct cAMP-mediated enhancement of glucose-dependent insulin release in pancreatic beta-cells. Here we show that GPR119 also stimulates incretin hormone release and thus may regulate glucose homeostasis by this additional mechanism. GPR119 mRNA was found to be expressed at significant levels in intestinal subregions that produce glucose-dependent insulinotropic peptide and glucagon-like peptide (GLP)-1. Furthermore, in situ hybridization studies indicated that most GLP-1-producing cells coexpress GPR119 mRNA. In GLUTag cells, a well-established model of intestinal L-cell function, the potent GPR119 agonist AR231453 stimulated cAMP accumulation and GLP-1 release. When administered in mice, AR231453 increased active GLP-1 levels within 2 min after oral glucose delivery and substantially enhanced total glucose-dependent insulinotropic peptide levels. Blockade of GLP-1 receptor signaling with exendin(9-39) reduced the ability of AR231453 to improve glucose tolerance in mice. Conversely, combined administration of AR231453 and the DPP-4 inhibitor sitagliptin to wild-t...Continue Reading

References

Apr 1, 1992·European Journal of Clinical Investigation·R EisseleB Göke
Feb 1, 1990·Scandinavian Journal of Gastroenterology·J Holst PedersenN Palmgren
Oct 1, 1995·The Journal of Endocrinology·C Herrmann-RinkeB Göke
Nov 9, 2001·Nature·F Rodríguez de FonsecaD Piomelli
Jul 12, 2002·American Journal of Physiology. Endocrinology and Metabolism·Connie Chisholm, Gordon R Greenberg
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Bo AhrénAnja Schweizer
Aug 28, 2004·Diabetes·Carolyn F Deacon
Dec 21, 2004·Biochemical and Biophysical Research Communications·Takatoshi SogaKiyoshi Furuichi
Dec 28, 2004·Nature Medicine·Akira HirasawaGozoh Tsujimoto
Feb 22, 2005·Biochemical and Biophysical Research Communications·Susumu KatsumaGozoh Tsujimoto
Mar 23, 2005·Regulatory Peptides·Carolyn F Deacon
Dec 17, 2005·Biochemical and Biophysical Research Communications·Tetsuya AdachiGozoh Tsujimoto
Jan 18, 2006·Annual Review of Medicine·Laurie L Baggio, Daniel J Drucker

❮ Previous
Next ❯

Citations

Oct 23, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Luciano De Petrocellis, Vincenzo Di Marzo
Feb 12, 2013·Archives of Pharmacal Research·Hyae Gyeong Cheon
Jul 31, 2013·Archives of Pharmacal Research·Tae-Young HaJae-Keol Rhee
Jan 6, 2010·Expert Reviews in Molecular Medicine·Helen E ParkerFiona M Gribble
Jun 20, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S S Hussain, S R Bloom
Sep 26, 2013·Nature Reviews. Gastroenterology & Hepatology·John B FurnessBrid Callaghan
Jun 12, 2010·Current Opinion in Clinical Nutrition and Metabolic Care·Jaimini CeglaStephen R Bloom
May 19, 2011·Current Opinion in Clinical Nutrition and Metabolic Care·Da Young Oh, William S Lagakos
Jan 15, 2013·Current Opinion in Gastroenterology·Per M Hellström
Oct 13, 2009·Diabetes, Obesity & Metabolism·M A KebedeV Poitout
Aug 17, 2011·Diabetes, Obesity & Metabolism·B Ahrén
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Jun 13, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Stephanie M YoderPatrick Tso
Feb 18, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jing MaChristopher K Rayner
Aug 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Venkat VangavetiR Lee Kennedy
Nov 17, 2010·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Shigeru Yoshida
Jan 21, 2012·The Review of Diabetic Studies : RDS·Carolyn F Deacon, Bo Ahrén
Feb 15, 2012·Advances in Nutrition·Sofia Moran-RamosNimbe Torres
Feb 8, 2014·Molecular Phylogenetics and Evolution·Kavita Kumari Kakarala, Kaiser Jamil
Nov 20, 2013·Annual Review of Physiology·Young Min ChoTimothy J Kieffer
May 3, 2014·Reviews in Endocrine & Metabolic Disorders·Amandine Everard, Patrice D Cani
Jan 24, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S PatelH M Cox
Jan 24, 2013·American Journal of Physiology. Endocrinology and Metabolism·Yan LiRobert F Margolskee
Sep 29, 2009·Expert Opinion on Therapeutic Patents·Robert M JonesJuerg Lehmann
Mar 1, 2010·Expert Review of Clinical Pharmacology·Thomas D AicherAnthony Celeste
Jan 30, 2016·Nature Reviews. Drug Discovery·Da Young Oh, Jerrold M Olefsky
Feb 28, 2013·Expert Opinion on Investigational Drugs·Lauren M CornallAndrew J McAinch
Feb 2, 2012·Expert Opinion on Investigational Drugs·Takahide Ohishi, Shigeru Yoshida

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.